NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Accelerant Agrees to $4.4 Billion Take-Private Deal with Thoma Bravo

Shareholders get $20.25/share (49% premium). Expected close: H1 2027.

Accelerant Agrees to $4.4 Billion Take-Private Deal with Thoma Bravo
Credit: Michael Nagle/Bloomberg
Already have an account? Sign in.
Featured/ 08/13/2026 · 7:29 AM
ARX
/ Read more

Feed↓

IREN Completes Horizon 1 for Microsoft, Achieves Top NVIDIA Cloud Certification
08/13/2026 · 8:37 AM

IREN Completes Horizon 1 for Microsoft, Achieves Top NVIDIA Cloud Certification

IREN delivers Horizon 1 AI data center to Microsoft and achieves NVIDIA Exemplar Cloud status. First of four 50MW facilities in $9.7B Texas deal.

/ Subscriber only
Tapestry Beats on Earnings as Coach Thrives, but Soft Revenue Guidance Weighs on Shares
08/13/2026 · 7:57 AM

Tapestry Beats on Earnings as Coach Thrives, but Soft Revenue Guidance Weighs on Shares

Tapestry posted Q4 adjusted EPS of $1.32 above consensus, powered by Coach. Kate Spade weakness led to cautious FY27 revenue guidance of $8.4–$8.5B.

/ Subscriber only
Morgan Stanley Starts Coverage of Achieve Life Sciences at Overweight with $13 Price Target
Featured/ 08/13/2026 · 7:08 AM

Morgan Stanley Starts Coverage of Achieve Life Sciences at Overweight with $13 Price Target

Achieve's smoking-cessation drug impressed analysts with strong trial results, putting the company on track for possible FDA approval in 2027.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe